HSF1 is the major heat shock transcriptional factor that binds heat shock element (HSE) in the promoter of heat shock proteins (Hsps) and controls rapid Hsp induction in cells subjected to various environmental stresses. Although at least four members of the vertebrate HSF family have been described, details of their individual physiological roles remain relatively obscure. To assess whether HSF1 exhibited redundant or unique in vivo functions, we created Hsf1 -/-deficient mice. We demonstrate that homozygous Hsf1 -/-mice can survive to adulthood but exhibit multiple phenotypes including: defects of the chorioallantoic placenta and prenatal lethality; growth retardation; female infertility; elimination of the 'classical' heat shock response; and exaggerated tumor necrosis factor alpha production resulting in increased mortality after endotoxin challenge. Because basal Hsp expression is not altered appreciably by the HSF1 null mutation, our findings suggest that this factor, like Drosophila Hsf protein, might be involved in regulating other important genes or signaling pathways. Our results establish direct causal effects for the HSF1 transactivator in regulating critical physiological events during extraembryonic development and under pathological conditions such as sepsis to modulate pro-inflammatory responses, indicating that these pathways have clinical importance as therapeutic targets in humans.
Introduction
The heat shock transcription factor 1 (HSF1) gene belongs to a family of vertebrate HSF transactivators, and encodes the orthologous protein found across the eukaryotic phyla (Morimoto, 1998) . Originally identified in crude extracts of heat-shocked Drosophila as a heat shock element (HSE) binding activity in hsp promoters and chromatin (Wu, 1984) , HSF was subsequently purified and characterized from yeast and flies (Sorger and Pelham, 1987; Wiederrecht et al., 1987; Sorger and Nelson, 1989) . A single-copy HSF gene was identified in Saccharomyces cerevisae (Sorger and Nelson, 1989) and Drosophila (Clos et al., 1990) , respectively, and three genes encoding HSFs were isolated in plants (Scharf et al., 1990) . The hierarchy of the HSF family in vertebrates was established by cloning two HSFs from mice, mHSF1 and mHSF2 (Sarge et al., 1991) , two HSFs, hHSF1 and hHSF2 (Schuetz et al., 1991) from humans, three HSFs from chicks (Nakai and Morimoto, 1993) and, most recently, a fourth novel factor, hHSF4, from human cells (Nakai et al., 1997) . Despite the increasing number of vertebrate HSFs over the past few years, and the notion that each imparts unique physiological functions in the cells of complex organisms (reviewed in Wu, 1995) , little specific knowledge is available about the in vivo biological roles of individual mammalian HSFs.
The remarkably conserved heat shock response is among the best characterized endogenous mechanisms in prokaryotic and eukaryotic cells alike, essential for host defense and survival (Lindquist and Craig, 1988) . The best known function of HSF is transactivation of hsp gene expression in response to heat, chemical and pathophysiological stress such as ischemia in diverse eukaryotic cell types from yeast to humans (Morimoto, 1998) . The detailed mechanisms by which diverse physiological stresses converge to activate the common HSF regulatory pathway have been deciphered (Morimoto et al., 1994; Zhong et al., 1998) . In addition, phylogenetic and structural studies have established that eukaryotic HSFs are organized into functional domains beginning with a conserved DNA-binding region at the N-terminus, an adjacent oligomerization domain comprised of multiple hydrophobic repeats (or leucine zippers), a nuclear localization signal and a C-terminal transactivation domain (Wu, 1995) .
In contrast to HSF in yeast, HSF1 of higher eukaryotes exists in the unstressed cell as an inactive monomer whose basal activity is negatively regulated, at multiple levels, by a C-terminal hydrophobic repeat domain (Rabindran et al., 1993) , the chaperone Hsp90 (Zou et al., 1998) , and to a lesser degree by Hsp/c70 repressor complexes (Rabindran et al., 1994) . In response to physiological stress, HSF monomers aggregate into homotrimers that bind avidly within the major groove of DNA at conserved nGAAn repeats and activate target hsp genes (Amin et al., 1988) . This process is also associated with phosphorylation at serine and threonine HSF residues through signal transduction involving the mitogen-activated protein kinase pathways, which are reversible upon stress withdrawal (Knauf et al., 1996) .
Rapid synthesis of stress proteins in the cell is widely believed to play a pivotal role in defense against proteotoxic damage during adverse (patho)physiological conditions such as myocardial infarction and sepsis (Morimoto et al., 1994; Wu, 1995) . Stress proteins (Hsps) function as molecular chaperones to facilitate proper folding of nascent polypeptides, maintain proteins in their native folded state, and repair or promote degradation of unfolded proteins (Gething and Sambrook, 1992; Parsell et al., 1993) . Transgenic studies have provided compelling evidence that overexpression of stress proteins (e.g. hsp70) can mitigate the effects of pathological conditions simulating heart attacks and strokes in animals (reviewed in Benjamin and McMillan, 1998) . These observations have important implications for other pathological states, including febrile illness, sepsis, cancer, Alzheimer's disease and other degenerative diseases associated with oxidative stress in aging humans. However, a lack of available robust experimental models to test directly the functional roles of stress-inducible Hsp expression or regulatory networks in vivo has hindered progress.
In addition to playing a key role in the response to noxious stimuli, vertebrate HSFs are widely believed to play a role in spontaneous hsp gene expression during embryogenesis, organogenesis, development and postnatal growth (Tanguay et al., 1993) . Mutagenesis studies using a heterologous Hsp70.1 promoter to regulate transgene expression have implicated HSF1 during zygotic genome activation (Christians et al., 1997) . In vitro studies of the structurally homologous factor, HSF2, have demonstrated its HSE-DNA binding both after hemin treatment during differentiation of K562 erythroleukemia cells (Sistonen et al., 1992) and in extracts from mouse blastocysts and embryonic tissues (Loones et al., 1997) . Together, the available evidence that HSFs play crucial roles during development is primarily indirect and correlative; furthermore, no prior study has provided direct functional evidence for mammalian HSFs in vivo. Accordingly, we have undertaken a systematic approach using gene targeting to elucidate the regulatory effect that mammalian HSFs exert during physiological growth and development.
Details of the gene targeting strategy used in our laboratory to create homozygous Hsf1 -/-mice have been reported . The deletion encompasses~80% of the DNA-binding domain and the three leucine zippers (1-3) that comprise the oligomerization domain. Although a mutant mRNA transcript was produced, with a predicted in-frame open reading frame (ORF) deletion of 301 amino acids (31 kDa), we detected no corresponding immunoreactive proteins using available HSF1 antiserum in both in vitro and in vivo systems. In previous in vitro analysis of HSF1 functions, we have demonstrated that Hsf1 -/-cells derived from mouse embryos exhibited markedly increased susceptibility to heat-induced apoptosis, indicating non-redundant and essential roles for HSF1 during thermotolerance . In this report, we have focused on the unexpected findings implicating new functions for HSF1 expression during development of the chorioallantoic placenta and postnatal growth in Hsf1-deficient mice. In addition, we demonstrate here that Hsf1 -/-mice, despite lacking a 'classical heat shock' response, can survive into adulthood but sustain increased mortality associated with exaggerated production of the proinflammatory cytokine, tumor necrosis factor α (TNF-α), after endotoxemic and inflammatory challenge.
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Results
Homozygous Hsf1 -/-mice exhibited prenatal lethality Table I shows the results of Hsf1 ϩ/-heterozygous (F 1 ) intercrosses from separate mating between germline chimeric males (ES cells, 129SvEv) to 129SvJ, inbred BALB/c and outbred ICR wild-type females, respectively. Accordingly, these targeted mutant strains are referred to herein as follows: 129SvJϫ129SvEv (129-Hsf1), BALB/c ϫ129SvEv (C,129-Hsf1) and ICRϫ129SvEv (R,129-Hsf1), respectively. Breeding to homozygosity produced live Hsf1 -/-progeny that were recovered at less than the predicted Mendelian distribution in all three genetic backgrounds (129-Hsf1 or C,129-Hsf1 or R,129-Hsf1 strains; p Ͻ0.01). Only two of 165 (1.2%) 129-Hsf1 live births were homozygotes from 43 litters. In contrast, survival of F 2 Hsf1 -/-mice in either the C,129-Hsf1 (23 of 195 or 11.8%) or R,129-Hsf1 (20 of 133 or 15%) background was an order of magnitude higher than that of the 129-Hsf1 mutant strain (p Ͻ0.01), indicating variable penetrance in different genetic backgrounds.
Based on widespread HSF1 expression in vivo, the lesion causing prenatal lethality in Hsf1 -/-mice could manifest at various stages of embryogenesis. Table II shows the results of 129-Hsf1 heterozygous intercrosses in the most severely affected strain resulting in embryonic lethality. Between 10.5 and 11.5 days post-coitus (d.p.c.), we found the expected Mendelian distribution of viable embryos examined (n ϭ 149), indicating that haploinsufficiency of HSF1 expression affected neither fertilization nor pre-implantation in mice. Thereafter, the number of 129-Hsf1 homozygous embryos found alive after 12.5 d.p.c. decreased dramatically such that at 13.5 d.p.c. only 35% (7/20) of these embryos were observed with beating hearts (Table II) . Between 14.5 and 17.5 d.p.c., we analyzed an additional seven litters containing 43 of the 129-Hsf1 embryos and found that Ͻ3% of Hsf1 -/-embryos (1/43) of the predicted Mendelian distribution were alive (Table II; expected Hsf1 -/-versus observed; p Ͻ0.05). Given the paucity of 129-Hsf1 live births (1.2%; Table I ), we conclude that prenatal lethality in the most severely affected 129-Hsf1-deficient animals mainly occurred around 14.0 d.p.c. Interestingly, the timing of embryonic lethality was less sharply demarcated in both C,129-and R,129-Hsf1 mutant strains, and occurred between the window from late mid-gestation to birth (Tables I and II) .
HSF1 is required for development of chorioallantoic placenta
Based on the proposed crucial roles for HSF1 expression in basal Hsp expression (Fiorenza et al., 1995) , coincident with the metabolic requirements during rapid embryonic growth, we first analyzed viable embryos in the targeted mutation strains at 11.5, 12.5 and 13.5 d.p.c., in anticipation of finding embryonic defects. No distinguishable morphological or microscopic abnormalities were detected in multiple solid or soft tissues (i.e. brain, heart, liver, kidney, striated muscle, smooth muscle, bone, cartilage and bone marrow) in different mutant strains examined extensively at varying developmental stages ( Figure 1A ; data not shown). Besides the absence of primary abnormalities in organ structures, we found that no histopathological features consistent with secondary complications associated with lethality at these developmental periods, such as congestive heart failure, pulmonary congestion or other organ failure, were present in the embryo proper and adult animals. To determine whether prenatal lethality associated with Hsf1 deficiency involved extra-embryonic sites, we next characterized extensively the chorioallantoic placenta. By mid-gestation, the chorioallantoic placenta consists of three morphologically distinct layers: the decidua layer of mixed origin, and the spongiotrophoblast and labyrinthine trophoblast giant cell layers, both of embryonic origin. Beginning at 11.5 d.p.c., all three layers were found to be indistinguishable in both wild-type ( Figure 1B , a, c and e) and heterozygous Hsf1 ϩ/-(data not shown) concepti of the 129-Hsf1 or C,129-Hsf1 hybrid background. In contrast, a marked thinning of the spongiotrophoblast layer at 11.5 d.p.c. disrupted this normal architecture in Hsf1 -/-embryos of both 129-Hsf1 and C,129-Hsf1 strains (data not shown), which was more pronounced at 13.5 d.p.c. ( Figure 1B , b, d and f). In agreement with our histological studies, in situ hybridization studies using a lineagespecific marker for spongiotrophoblast-the tyrosine kinase 5945 receptor for vascular endothelial growth factor, Flt-1 (Breier et al., 1995) -confirmed that the Flt-1 transcript was dramatically reduced in the Hsf1 -/-placentas compared with wild-type placentas in both 129-Hsf1 and C,129-Hsf1 strains at 13.5 d.p.c. ( Figure 1C , arrowheads in b and d, respectively). In contrast, expression of the proliferin transcript, PLF-1A, a specific marker for trophoblast giant cells of the labyrinth (Carney et al., 1993) , was unaltered in Hsf1-deficient mice, indicating that the spongiotrophoblast defects occurred without other compensatory changes or proliferative responses in these cells at 13.5 d.p.c. (data not shown).
To determine whether surviving Hsf1 -/-animals at later developmental stages exhibited the wild-type or mutant morphology, we intercrossed homozygous male and heterozygous Hsf1 female mice and analyzed the concepti of C,129-Hsf1 strain at 18.5 d.p.c. Whereas the placentas of C,129-Hsf1 heterozygous animals exhibited a normal appearance with hypercellularity and vascularization, prominent abnormalities such as reduced organ size, fibrin deposits, vacuolization, degeneration and significant hemorrhages were detected in the labyrinth, even in mutant embryos alive at 18.5 d.p.c. ( Figure 1B , i and j). Therefore, the consistent spongiotrophoblast defects in both strains at late mid-gestation, 13.5 d.p.c. ( Figure 1B , f and j, arrow), along with histopathological abnormalities at late gestation, indicated that deficiencies of HSF1 functions were confined and restricted to extra-embryonic tissues of the chorioallantoic placenta throughout in utero development.
Spontaneous Hsp expression is unaffected in Hsf1-deficient mice
To determine first whether embryonic viability was associated with alterations in Hsp gene expression in the embryo proper, we examined representative members of the Hsp multigene family, beginning at mid-gestation. By Western blot analysis, we found equivalent concentrations of Hsp90α, Hsc70, Hsp70 and Hsp25 proteins between 11.5 and 13.5 d.p.c. in both wild-type and 129-Hsf1 homozygous embryos (Figure 2A ). In particular, indirect immunohistochemical labeling of sagittal sections of wildtype and Hsf1 -/-embryos at 13.5 d.p.c. correlated with quantitative findings in that Hsp90β and Hsc70 proteins, for example, were expressed ubiquitously with a remarkably high level of Hsp90β labeling in the central nervous (Table II) . In the C,129-Hsf1 strain, discontinuous tissues of the spongiotrophoblast could still be seen at 13.5 d.p.c. between the decidua and labyrinthine trophoblast layers (f, arrow). d, decidua; l, labyrinth; s, spongiotrophoblast. Scale bars ϭ 250 μM, except g and h ϭ 1 mm. (C) Expression of vascular endothelial receptor Flt1 identifies the spongiotrophoblast defect. In situ hybridization indicated that the lineage-specific marker Flt-1 transcript was expressed abundantly in the spongiotrophoblast layer of wild-type embryo placentas at 13. system, dorsal root ganglia, liver and lung, whereas Hsp25 was concentrated in cardiac and skeletal muscles ( Figure 2B ). Similar patterns of basal expression were obtained from immunohistological analyses in wild-type, Hsf1 ϩ/-and Hsf1 -/-adult animals in the C,129-Hsf1 background, indicating that both spatial and temporal Hsp expression patterns were unaltered by inactivation of the Hsf1 gene (discussed below).
We next tested the hypothesis that extra-embryonic tissue was an important target for the heat shock response. Immunohistochemical staining of 13.5 d.p.c. 129-Hsf1 embryos indicated that the HSF1 protein was localized in the nucleus of trophoblastic cells in all layers of wildtype mice, and was expectedly absent in Hsf1 -/-placentas ( Figure 2C ). However, we observed neither spatial nor temporal differences in the expression patterns of Hsp90α, Hsp70 and Hsp25 proteins between wild-type and homozygous animals in all layers of the placenta (data not shown), indicating the placental defects could be dissociated from the expression of these Hsp proteins.
Hsf1-deficient mice exhibited postnatal growth retardation
In assessing the potential effects of placental defects on postnatal growth and development, we observed that both male and female Hsf1 -/-mice appeared smaller than either wild-type or heterozygous littermates. Beginning the first postnatal week, the average weights of C,129-Hsf1 homozygotes (male ϭ 26; female ϭ 29) were significantly lower than those of wild-type (F 2 ) littermates (male ϭ 16; female ϭ 7), a result that is consistent with but does not conclusively establish that Hsf1 deficiency in utero In agreement with Western blot analysis, there were no differences between the wild-type and Hsf1 homozygous animals by immunohistochemical analysis. Hsp90β was expressed ubiquitously but high levels could be seen in the central nervous system, dorsal root ganglions, liver, lungs and skeletal muscles; in contrast, Hsp25 was localized mainly in the heart and skeletal muscles. d, dorsal root ganglion; h, heart; l, liver; lg, lung; m, skeletal muscle; sc, spinal cord. (C) Immunohistochemical staining showed that HSF1 protein was as expected absent in the placentas of Hsf1 -/-embryos but was localized intensely in the nucleus of trophoblast cells, especially in the spongiotrophoblast of wild-type placentas ( Figure 1C, arrowheads) . Weak staining of HSF1 protein in decidua of the mutant was derived from maternal Hsf1 ϩ/-tissues (d, decidua; l, labyrinth; s, spongiotrophoblast).
contributed to growth retardation at birth ( Figure 3B and C) (p Ͻ0.01). In addition, the average body weights of C,129-Hsf1 -/-mice lagged behind their wild-type and heterozygous littermates, and this difference increased further after weaning, strongly suggesting that HSF1 expression was required for normal postnatal growth ( Figure 3B and C). Growth retardation was independent of sex; male homozygotes were 77% of normal ( Figure 3B ), whereas female homozygotes were 78% of normal after 8 weeks ( Figure 3C ; ϩ/ϩ versus -/-; p Ͻ0.01). We also observed that average weights of Hsf1 -/-mice in another hybrid strain (e.g. B6,129-Hsf1) were similar to those reported presently in C,129-and R,129-Hsf1 strains ( Figure 3C ; data not shown). Because the plasma levels of sex steroid (estradiol, estrone and progesterone) and glucocorticoid (corticosterone) were similar in wild-type (n ϭ 4) and C,129-Hsf1 -/-(n ϭ 4) adult female mice (data not shown), growth retardation in Hsf1 inactivation 5947 appeared to be unrelated to disruption of the adrenalpituitary axis.
We routinely obtained litters from intercrosses between wild-type or heterozygous females and multiple strains of Hsf1 -/-males, indicating that this mutation has no effect on fertility in males. However, no Hsf1 -/-females (n ϭ 8) produced any litters when mated for extended periods (~3 months) with fertile males of all three genotypes. More thorough and detailed analyses of HSF1's potential roles in female infertility in pre-implantation (e.g. early cleavage) and post-implantation development (e.g. decidua response) are in progress and will be reported elsewhere (manuscript in preparation).
Disruption of HSF1 eliminates the heat shock response in adult Hsf1 null mice
Our previous in vitro studies using mouse embryonic fibroblasts (MEFS) have demonstrated that the null mutation completely abrogated the capacity of Hsf1 -/-cells to acquire thermotolerance, and thereby significantly increased their susceptibility to and reduced their protection against heat-induced apoptosis . No differences in thermal protection were found between wild-type and heterozygous Hsf1 cells. Whereas no HSF1 protein was detected in any tissues of Hsf1 -/-mice, we found that expression of HSF1 protein was reduced to~50% of wild-type levels in C,129-Hsf1 heterozygous animals ( Figure 4A ). To assess whether other HSFs, besides HSF1, conferred heat shock responsiveness in vivo, adult mice of all three genotypes in the hybrid C,129-Hsf1 background were subjected to heat shock (42°C for 15 min) and the heat shock response was assessed after 24 h. In agreement with our in vitro analysis , concentrations of the major classes of Hsps (Hsp70/c70, Hsp90α,β, Hsp60 and Hsp25) were increased dramatically in multiple tissues (e.g. heart, brain, liver and kidney), but similar levels were observed in wild-type and Hsf1 ϩ/-animals after heat shock ( Figure 4B and C). However, Hsp induction was predictably abolished in all tissues of Hsf1 -/-mice, indicating that other members of the mammalian HSF family do not compensate during inducible hsp gene expression in vivo ( Figure 4B and C).
Disruption of Hsf1 increases mortality and exaggerates TNF-α production during endotoxemia
Although we observed no adverse outcomes among all three genetic groups under confinement and normal handling in their cages, we next tested the hypothesis that Hsf1 inactivation would reduce stress tolerance of the organism in response to systemic challenges. Several previous studies have demonstrated that pre-treatments with either heat stress or chemicals (e.g. sodium arsenite), which induced multiple Hsps, improved the survival in several rodent models challenged by endotoxin, a component of lipopolysaccharide (LPS) of Gram-negative bacteria (Hotchkiss et al., 1993; Ribeiro et al., 1994) . To assess the functions of constitutive Hsps, and physiological consequences of a muted heat shock response in vivo, wild-type (n ϭ 19), heterozygous (n ϭ 18) and homozygous C,129-Hsf1 mice (n ϭ 20) of both sexes were administered LPS intraperitoneally (i.p.), and survival rates were monitored for 96 h. The LD 50 of Escherichia coli LPS (25 mg/kg body weight) was determined in preliminary studies using this mixed genetic background (data not shown). Figure 5A shows that the survival rate of C,129-Hsf1 -/-mice was significantly lower (35% after 4 days) than that of wild-type controls and heterozygotes (63.2 and 60% after 4 days, respectively) after LPS exposure, with death in 40% of mutant mice occurring after 48 h (ϩ/ϩ versus -/-; χ 2 test for survival, p Ͻ0.05). Thus, laboratory mice bearing inactivation of HSF1 expression exhibited increased mortality during pathological challenges mimicking lethal inflammatory stimuli in humans.
Multiple factors might influence differences in susceptibility to LPS treatment, including the heat shock response, co-stimulatory effects on NFκB and IκB activation and degradation, increased oxidative stress/damage, and acutephase proteins such as pro-inflammatory cytokines. Consistent with earlier studies (Hotchkiss et al., 1993) , we found negligible changes in the concentrations of stressinducible Hsp70 in multiple tissues (liver, heart) and time points (12-24 h) after endotoxin treatment (data not shown). To determine whether HSF1 expression exerted direct effects on cytokine production, we examined levels of TNF-α and interleukin 10 (IL-10) using quantitative ELISA during the acute-phase response after endotoxin administration (see Materials and methods). Within 90 min after LPS, robust induction of TNF-α production in the plasma of C,129-Hsf1 -/-(n ϭ 8) animals had significantly increased by 2-fold above the levels of heterozygous (n ϭ 11) control animals ( Figure 5B ; ϩ/-versus -/-; p Ͻ0.05). In contrast, the anti-inflammatory cytokine IL-10 was not significantly different and slightly greater in Hsf1 -/-(n ϭ 13) than heterozygous (n ϭ 11) animals ( Figure 5C ). Thus, reduced survival of Hsf1 -/-animals Concentrations of HSF1 protein were assessed by Western blot analysis in the brain, testis, heart and liver of adult wild-type mice (C,129-Hsf1 strain). HSF1 protein was correspondingly reduced bỹ 50% in heterozygous animals; however, neither full-length HSF1 nor truncated HSF1 protein was found in any tissues of Hsf1 -/-mice. (B) Hsf1 null mutation abolishes the heat shock response in vivo. Groups of wild-type (n ϭ 3), heterozygous (n ϭ 3) and null (n ϭ 3) adult C,129-Hsf1 mice were anesthetized and subjected to heat shock (42°C for 15 min) and recovered for 24 h as described in Materials and methods. Control animals of all three genotypes (n ϭ 3 animals/ group) were anesthetized but not exposed to heat shock conditions. Animals were killed after 24 h and protein extracts from different tissues were analyzed by Western blotting. Note that the average constitutive levels of the major Hsp classes under non-stressed conditions were unaltered in all genotypes (ϩ/ϩ, ϩ/-, -/-) of C,129-Hsf1 -/-mice. The heat shock response was completely abolished in Hsf1 -/-mice, which was in agreement with previous in vitro analysis . Differences in the heat shock response were assessed by densitometry scans using representative scans for Western blotting (e.g. Hsp70 protein), as shown in (C). The fold changes for Hsps were plotted in arbitrary units as the ratios obtained under heat shock and non-stressed conditions. correlated mainly with exaggerated production of the pro-inflammatory cytokine TNF-α, but not with stressinducible Hsp expression, after single-dose endotoxemic challenge in mice ( Figure 5A-C) , implicating a direct role of HSF1 deficiency in pathological states in mice.
Discussion
To date, genetic studies of the in vivo functions of orthologous HSFs have indicated that yeast HSF is essential for viability (Sorger and Pelham, 1988) , whereas Drosophila HSF protein is required for oogenesis but is dispensable for growth and viability under non-stress conditions (Jedlicka et al., 1997) . Since the discovery of multiple HSF transactivators in vertebrates, our under- Reduced survival and increased TNF-α production of Hsf1-deficient mice after LPS challenge. Escherichia coli LPS was administered as a single dose (25 mg/kg) i.p. to groups of wild-type (n ϭ 19), heterozygous (n ϭ 18) and null (n ϭ 20) adult C,129-Hsf1 mice, and the survival rates were monitored for 4 days. A statistically significant higher survival rate was found for wild-type than Hsf1 -/-adult mice after 4 days (63.2% versus 35.0%) after LPS (χ 2 test for survival analysis between wild-type and Hsf1 -/-mice, p Ͻ0.05).
(B and C) Heterozygous mice, which exhibited similar survival rates as wild-type controls, were treated similarly to Hsf1 -/-animals with LPS and the plasma levels of inflammatory cytokines (TNF-α and IL-10) were determined 90 min after LPS treatment using ELISA. In Hsf1 -/-animals, the plasma levels of TNF-α were significantly increased by 100% above heterozygous controls exhibiting a lower and similar mortality to wild-type animals (A). LPS did not significantly increase levels of Hsps, in agreement with others (data not shown), indicating that alterations in the production of proinflammatory cytokine can be dissociated from the heat shock response.
standing of their precise physiological roles has lagged substantially behind extensive analysis of their biochemical, structural and regulatory properties, especially during the stress response. Surprisingly, exhaustive studies of homozygous animals excluded a primary role for HSF1 expression in the development of the embryo proper in mice. HSF1 expression was unexpectedly required for extra-embryonic development, beginning at mid-gestation (Table I) . Interestingly, the severity of prenatal lethality and survival of Hsf1 mutant mice were influenced by the genetic background. Although this well-recognized effect is not infrequent in gene knockouts in mice (Threadgill et al., 1995) , variable penetrance of Hsf1 mutation on survival suggested that the presence of genetic modifiers is involved in extra-embryonic development.
Hsf1 deficiency and chorioallantoic placenta development
Genetic studies in mice have implicated several factors in determining the cell fate and differentiation of major trophoblast cell lineages in post-implantation development. Normal histomorphological appearance of the decidua layer, containing cells of both maternal and fetal origin, and the labyrinth, containing trophoblast giant cells, in Hsf1 -/-animals indicated that HSF1 expression was dispensable in the development of these cell lineages. All Hsf1 -/-placentas examined in both 129-Hsf1 and C,129-Hsf1 strains exhibited similar histopathological abnormalities of the spongiotrophoblast lineage, indicating that the cell and tissue requirements were specific for HSF1. In the most severely affected 129Sv strain (1.2% live births), Hsf1 -/-embryos perished at late mid-gestation, which limited the recovery of additional Hsf1 -/-embryos due to reabsorption. The timing of prenatal death in the C,129-Hsf1 (11.8%) and R,129-Hsf1 (15%) strains is likely to have occurred between embryonic day (E) 14.5 and birth, which exhibited increased survival rates (Table II) .
The mechanism for the unexpected findings of placentation defects caused by HSF1 inactivation remains to be elucidated fully but several possibilities are envisioned. Prior studies have shown that disruption of either Mash2 (Guillemot et al., 1994) or the estrogen-receptor-related receptor β (ERR-β) (Luo et al., 1997) results in arrested differentiation of the spongiotrophoblast layer. In contrast to Mash2 -/-or ERR-β -/-, in which embryonic lethality occurred at early mid-gestation (~10.5 d.p.c.), disruption of Hsf1 -/-produced embryonic lethality later in midgestation at~14.0 d.p.c., suggesting possible requirements for downstream targets of HSF1 expression that play critical roles for maintenance of the differentiated spongiotrophoblast. Since we recovered viable C,129-Hsf1 concepti that exclusively exhibited the characteristic abnormalities in extra-embryonic tissue, we conclude that the changes found in the labyrinth at late gestation (18.5 d.p.c.) were secondary to the primary lesions of the spongiotrophoblast at mid-gestation.
In contrast to earlier studies indicating induction of hsp70 expression in the placentas at 8.5 d.p.c. and in the yolksac at 11.5 d.p.c. in mice (Kothary et al., 1987) , we found that extra-embryonic abnormalities were disassociated from appreciable changes in basal Hsp levels, at late mid-gestation ( Figure 1C ; data not shown). Interestingly, immunohistochemical studies of placentas in human subjects have indicated no direct correlation between expression patterns of multiple Hsps (e.g. Hsp72/73, Hsp60 and Hsp27) and gestational age or clinical endpoints in later pregnancy (Divers et al., 1995; Li et al., 1996) . We hypothesize that HSF1 in vivo functions, like the Drosophila hsf protein (Jedlicka et al., 1997) , might target novel non-hsp genes in placental mammals.
Accordingly, multiple experimental approaches are being used currently to determine whether the complex placental phenotype involves members of the Hsp family and other novel targets, either alone or in combination. For example, future experiments such as rescue of the trophoblast defect are needed to clarify putative HSF1 in vivo functions in growth, both in utero and in postnatal development. In addition, homozygous Hsf1 mice of both sexes can survive to late adulthood (Ͼ2 years) with the notable exception that females, unlike Hsf1 -/-males, were infertile. Characterization of female Hsf1 -/-sterility, still in progress, will be reported separately (E. Christians and I.J.Benjamin, unpublished results) .
HSF1 is a positive and negative regulator
We have demonstrated that Hsf1 inactivation does not affect HSF2 expression, yet the heat shock stress response was completely abolished in Hsf1 null cells . Interestingly, Tanabe et al. (1998) have shown recently that inactivation of avian HSF3 revealed an unexpected requirement, along with chick HSF1, for full expression of stress tolerance in chick cultured cells, raising the important possibility that other vertebrate HSFs may share similar interactions. However, in multiple tissues of Hsf1 null animals, unimpaired HSF2 expression does not compensate for HSF1, as the main stress-inducible transactivator, during mammalian heat shock response.
In agreement with earlier studies in mice (Hotchkiss et al., 1993) , susceptible C,129-Hsf1 wild-type or heterozygous control animals, which were capable of Hsp induction, exhibited insignificant changes in Hsp concentrations after LPS treatment (I.J.Benjamin, unpublished results). Since HSF1 activation has been shown to suppress pro-interleukin 1β gene (proIL-1β) in human monocytes after LPS stimulation in vitro (Cahill et al., 1996) , evidence for significantly greater TNF-α production in Hsf1 -/-animals than in heterozygous controls is the first direct evidence supporting HSF1's in vivo role as a negative regulator. Thus, suppression of the pro-inflammaory cytokine TNF-α by HSF1 establishes a bona fide compensatory endogenous mechanism for protection during pathological challenges in mammals.
Implications of the Hsf1 knockout for future studies of disease pathogenesis
In conclusion, new findings for crucial requirements of HSF1 in vivo functions in post-implantation development suggest possible new avenues to identify novel genes and signal transduction pathways likely to impact reproductive development in mammals. Because Hsp chaperones have been shown to confer survival and protection against proteotoxic damage, upregulation of stress 'heat shock' proteins (Hsps) is widely believed to play a pivotal role in defense strategies during adverse (patho)physiological conditions. Such cytoprotective properties of Hsps have been implicated in inherited human genetic disorders such as cystic fibrosis, in acquired diseases such as Alzheimer's disease, ischemic heart disease and cancer, and in degenerative diseases of aging, all of which are likely to have abnormal protein structures as common pathogenic mediators (Dobson and Ellis, 1998) . That Hsf1 mutant mice can survive to adulthood should immediately accelerate applications of this experimental model to decipher whether direct causal relationships involve members of the stress-inducible Hsps in physiological health and pathological conditions.
Materials and methods
Targeting mutation strains and characterization of the Hsf1 null allele Hsf1 mice were created using homologous recombination with a genetargeting vector in ES cells as described recently . Germline male chimeras (ES cells, 129SvEv) or 129SvJ heterozygous males carrying the mutant Hsf1 allele were mated with wildtype females of 129SvJ (129,Hsf1), BALB/c (C,129-Hsf1), C57BL/6J (B6,129-Hsf1) and ICR (R,129-Hsf1) strains to produce their offspring (F 1 ). Mendelian ratios of live births were determined from the offspring (F 2 ) of the heterozygous intercrosses. Hsf1 mice in the 129Sv background were confirmed independently using a battery of available markers (Simpson et al., 1997) . Sequence analysis of the mutant HSF1 transcript by PCR showed that an in-frame splicing event from nucleotide ϩ118 to ϩ724 has deleted 606 bp and, subsequently, 202 amino acids within the HSF1 ORF, corresponding to~80% the DNA-binding domain plus leucine zippers 1-3 (Sarge et al., 1991) .
Histology
Staged mouse embryos and placentas were harvested and fixed at 4°C in 4% paraformaldehyde overnight, dehydrated in ethanol and infiltrated with paraffin. Paraffin-embedded samples were then sectioned at 5 μm and subsequently stained with hematoxylin and eosin (H & E) for histological examination or sectioned at 4 μm for immunohistochemistry and in situ hybridization.
Immunohistochemistry
Embryos and placentas were harvested and fixed as for histology. Sections were reacted overnight at 4°C with rabbit polyclonal anti-HSF1 (1:2000), a kind gift from R.Morimoto; rabbit polyclonal anti-Hsp90α (1:16 000) and -β (1:50) (anti-Hsp86 and 84, respectively) from Affinity Bioreagents, Inc.; rabbit polyclonal anti-Hsp70 (1:100 000), a kind gift from R.Tanguay; and rat monoclonal anti-Hsc70 (1:30) and rabbit polyclonal anti-Hsp25 (1:16 000) from Stressgen Biotechnologies Corp. (Victoria, BC, Canada). After incubation with the appropriate horseradish peroxidase (HRP)-conjugated second antibody at room temperature for 1 h, slides were developed with DAB chromogen (Dako Corp., Carpinteria, CA). Some slides were counterstained with H & E.
Immunoblotting
Whole-cell extracts were prepared from various organs by homogenization. Twenty micrograms of protein were electrophoresed and transferred to Immobilon-P membrane (Millipore), and probed with the aforementioned antibodies with the following modifications: rabbit polyclonal anti-HSF1 (1:5000), rabbit polyclonal anti-Hsp90α and -β (1:5000), rabbit polyclonal anti-Hsp70 (1:100 000), goat polyclonal anti-Hsp60 (1:5000), rat monoclonal anti-Hsc70 (1:5000) and rabbit polyclonal antiHsp25 (1:10 000). After incubation in the appropriate HRP-conjugated second antibody (Vector Laboratories), blots were developed using the Renaissance Chemiluminescence System (NEN Life Science Products).
In situ hybridization
Dr Janet Rossant provided plasmids pFlt-1, pMASH-2 and pGPLF-IA containing cDNA sequences of Flt-1, MASH-2 and PLF-IA genes, respectively. Flt-1 and MASH-2 were used as molecular markers specific for spongiotrophoblast cells and PLF-IA for trophoblast giant cells of the placentas (Carney et al., 1993; Guillemot et al., 1994; Breier et al., 1995) . Antisense and sense riboprobes were generated by in vitro transcription using the Maxiscript kit (Ambion Inc., TX) and labeled with [ 35 S]UTP (800 Ci/mmol). In situ hybridization was performed on paraffin-embedded placental sections as described (Wilkinson et al., 1987) . The slides were developed, counterstained with hematoxylin, and examined under the microscope using bright and darkfield optics.
Whole-body hyperthermic and LPS challenge
Wild-type and homozygous adult mice of both sexes in the C,129-Hsf1 background were anesthetized with 1.2% Avertin (Aldrich, WI) 250 mg/kg body weight i.p., treated with a sublethal heat shock by increasing the rectal temperature to 42°C for 15 min using a 250 A infrared heat lamp (General Electric), and then returned to their cages for 24 h recovery. Anesthetized control mice were kept under similar conditions without heat shock, and their body temperature maintained at 37 Ϯ 0.5°C. Mice in both experimental groups were administered 0.2 ml of 0.9% sodium chloride i.p. to compensate for insensitive water loss during the procedure and recovery periods.
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For the LPS study, adult C,129-Hsf1 animals, 4-5 months old, were injected i.p. with 25 mg/kg body weight of LPS from E.coli serotype 0111:B4 (Sigma) diluted in pyrogen-free normal saline and mortality monitored continuously for 4 days.
Cytokine assays
TNF-α and IL-10 levels in plasma were determined using an ELISA as described by the manufacturer (R & D Systems, Minneapolis, MN). Ninety minutes after administration of LPS or non-pyrogenic saline, Hsf1 -/-or heterozygous control mice were killed with sodium pentobarbital (55 mg/kg i.p.) and blood samples were extracted by intracardiac puncture. Plasma samples were collected in ice-cold heparinized (200 U/tube) Eppendorf tubes, centrifuged at 700 g for 10 min at 4°C. All assays were performed in duplicate using diluted (1:10) samples and a standard curve that was generated according to the manufacturer's instructions.
Densitometry
Western blots from three different animals of each genotype with or without heat shock were scanned and analyzed using IP Lab Gel 1.5C (Signal Analytics Corp., Vienna, VA). To compare the fold differences between genotypes in the respective tissues, the expression of each Hsp was normalized to the wild-type control (non-heat shocked) animals and the average fold changes from three separate experiments are shown.
Statistics
Differences in group means were compared by Student's t-test and differences in mortality after LPS treatment were assessed using the χ 2 test for survival. A p value of Ͻ0.05 was considered statistically significant.
